Among the in vivo studies on the role of NRF2 in obesity, the main conclusion from knock-out studies in mice is that the targeted disruption of NRF2 decreases adipose tissue mass and protects mice from long-term HFD-induced obesity [126,127]. Here, NFE2L2 is linked to obesity disorder.